In addition, gene profiling of human breast cancer has allowed the definition of at least five additional subgroups, including luminal A (LumA), luminal B (LumB), human epidermal growth factor receptor 2 (HER2)-enriched, basal-like, and normal-like [24,25,44]. This evidence concerns the gene ERBB2 and breast carcinoma.